Related content

The Anti-Cancer Activity of Noscapine: A Review

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 4, Iss. 1, 2009-01 ,pp. : 92-97

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetics, pharmacodynamics and metabolism of a novel anticancer agent for prostate cancer

By            

International Journal of Oncology, Vol. 41, Iss. 1, 2012-01 ,pp. : 337-344

Spandidos Publications

Access to resources Recommend Favorite

Gender differences in the metabolism and pharmacokinetics of the experimental anticancer agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA)

By Zhou Shufeng   Kestell Philip   Tingle Malcolm   Paxton James  

Cancer Chemotherapy and Pharmacology, Vol. 49, Iss. 2, 2002-02 ,pp. : 126-132

Springer Publishing Company

Access to resources Recommend Favorite

Preclinical Evaluations of Therapies Combining the Vascular Targeting Agent Combretastatin A-4 Disodium Phosphate and Conventional Anticancer Therapies in the Treatment of Kaposi's Sarcoma

By Li Lingyun   Rojiani Amyn M.   Siemann Dietmar W.  

Acta Oncologica, Vol. 41, Iss. 1, 2002-02 ,pp. : 91-97

Informa Healthcare

Access to resources Recommend Favorite

Bioavailability and Pharmacokinetics of Genistein: Mechanistic Studies on its ADME

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 10, 2012-12 ,pp. : 1264-1280

Bentham Science Publishers

Access to resources Recommend Favorite